Draft:Lambda

Lambda Therapeutic Research is a global full-service Clinical Research Organization (CRO) headquartered in Ahmedabad, India. Founded in 1998, the company offers comprehensive clinical research services to the biotechnology, and pharmaceutical companies. Lambda's mission is to provide innovative and high-quality solutions to accelerate the development of safe and effective medical therapeutics worldwide.

History:
Established in 1998 by Mrs. Bindi Chudgar, Lambda Therapeutic Research has grown into a prominent player in the clinical research industry. The company's foundation was built upon a vision of delivering cutting-edge clinical research solutions to global pharmaceutical innovators. Lambda's journey towards excellence has been marked by significant milestones, driven by both organic growth and strategic acquisitions. In 2019, Lambda strategically enhanced its North American footprint by acquiring Novum Pharmaceutical Research Services, a distinguished 50-year-old CRO. This strategic move, following the integration of Biovail’s R&D facilities in Canada in 2010, solidified Lambda’s position in North America. Operating under the unified brand of Novum Pharmaceutical Research Services in North America, Lambda now operates from its headquarters in Ahmedabad, India, with operational reach spanning Mehsana (India), Warsaw (Poland), London (UK), Toronto (Canada), Pittsburgh (USA), and Las Vegas (USA). The company's core mission centers around offering comprehensive clinical research services to the global innovator, biotech, and generic pharmaceutical industries.

With a focus on secure IT systems and streamlined processes, Lambda ensures timely project execution while maintaining compliance with stringent global regulatory standards. Lambda's regulatory track record speaks volumes, with over 60 successful international inspections and audits conducted by regulatory bodies such as the USFDA, EMEA, MHRA, EU member states, and other global authorities in the past five years.

Lambda's dedication to quality has earned recognition within the industry. Accolades such as the ‘Best Indian CRO’ by Frost & Sullivan (USA) and the title of ‘Great Indian Workplace’ by UBS Transformance underscore Lambda's commitment to excellence. Recent achievements include receiving the ‘Regulatory Excellence Award ' at the CPhI Awards 2023 and the ‘Industry Partner of the Year’ Award at the Global Generics & Biosimilar Awards 2023, reflecting Lambda's contributions to regulatory compliance and meaningful collaborations within the pharmaceutical and clinical research sectors.

Lambda has also been covered by Industry Outlook, under category "Top CROs " for year 2022 and 2023.